ASCO 2023: Head and neck highlights
ASCO 2023: Head and neck highlights
Baseline liquid biopsy results in treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC
Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma
HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active surveillance without compromising QoL
Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients
Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer
ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment for pStage III G/GEJ cancer
NSIA and BVGH aim to improve patient outcomes and access to quality cancer care
Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer
Maximising diagnosis of colon cancer with target screening
Optimising colon cancer care in Nigeria
Current MM diagnosis and treatment strategies